Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2022 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value

LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell...
July 26, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer

LAGUNA HILLS, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
July 10, 2017 09:30 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors

LAGUNA HILLS, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
July 06, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event

LAGUNA HILLS, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
June 13, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention

LAGUNA HILLS, Calif., June 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
June 09, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
May 31, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology

LAGUNA HILLS, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
May 08, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences

LAGUNA HILLS, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
May 02, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors

LAGUNA HILLS, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
April 19, 2017 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International

LAGUNA HILLS, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...